Ongoing Disclosure Notices – Manu Caddie

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Rua Bioscience Limited (Rua)
Date this disclosure made:
17-Mar-22
Date of last disclosure:
7-Dec-21
Director or senior manager giving disclosure
Full name(s):
Manu Caddie
Name of listed issuer:
Rua Bioscience Limited
Name of related body corporate (if applicable):
Position held in listed issuer:
Kaihautu - Head of Innovation and
Regulation of Rua
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Rua
Nature of the affected relevant interest(s):
Manu is a director and 50%
shareholder of New Zealand
Nutraceuticals Limited (NZNL).
NZNL is a limited partner of
Hikurangi Bioactives Limited
Partnership (HBLP) with a 40%
economic interest in HBLP. HBLP is
the registered holder and beneficial
owner of 17,554,367 (before the
transactions) and 4,000,000 (after
the transactions) ordinary shares in
Rua.
For that relevant interest-
Number held in class before acquisition or disposal:
7,021,747
Number held in class after acquisition or disposal:
1,600,000
Current registered holder(s):
HBLP
Registered holder(s) once transfers are registered:
NZNL, Hikurangi Enterprises Limited
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
N/A
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A

Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:
17/03/2022
Nature of transaction: Off-market sale
Name of any other party or parties to the transaction (if known):
Hikurangi Enterprises Limited and
NZNL
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
The aggregate consideration is
$6,122,507.56. NZNL's economic
interest in that consnideration via its
40% economic interest in HBLP is
$2,449,003
Number of financial products to which the transaction relates:
13,554,367
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
Yes. Note, however, that Manu
Caddie does not have control over
HBLP's operational decisions as to
whether to undertake these trades in
Rua's shares.
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
No. Prior written clearance was not
required for HBLP to trade as Manu
Caddie does not have control over
HBLP's operational decisions as to
whether to undertake these trades in
Rua's shares.
Date of the prior written clearance (if any):
N/A
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Rua
Nature of the affected relevant interest(s):
Manu is a director and 50%
shareholder of NZNL. NZNL is
purchasing 5,421,747 ordinary
shares in Rua from HBLP.
For that relevant interest-
Number held in class before acquisition or disposal:
0
Number held in class after acquisition or disposal:
5,421,747
Current registered holder(s):
HBLP
Registered holder(s) once transfers are registered:
NZNL
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
N/A
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:17/03/2022
Nature of transaction: Off-market purchase
Name of any other party or parties to the transaction (if known):HBLP
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$2,449,003.11
Number of financial products to which the transaction relates:
5,421,747
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
Yes
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Yes
Date of the prior written clearance (if any):
15/03/2022
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Ordinary shares in Rua
Nature of relevant interest:
Registered and beneficial holder
For that relevant interest,-
Number held in class:194,106
Current registered holder(s):Manu Caddie
For a derivative relevant interest,-
Type of derivative:N/A
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative (if any):
N/A
The price's specified terms (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative relevant interest,-
N/A
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:17-Mar-22
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:

---

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Rua Bioscience Limited (Rua)
Date this disclosure made:
17-Mar-22
Date of last disclosure:
8-Jun-21
Director or senior manager giving disclosure
Full name(s):
Manu Caddie
Name of listed issuer:
Rua Bioscience Limited
Name of related body corporate (if applicable):
Position held in listed issuer:
Kaihautu - Head of Innovation and
Regulation of Rua
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Rua
Nature of the affected relevant interest(s):
Manu is a director and 50%
shareholder of New Zealand
Nutraceuticals Limited (NZNL).
NZNL is the owner of 5,421,747
(before the transactions) and nil
(after the transactions) ordinary
shares in Rua.
For that relevant interest-
Number held in class before acquisition or disposal:
5,421,747
Number held in class after acquisition or disposal:
0
Current registered holder(s):
NZNL
Registered holder(s) once transfers are registered:
Manu Caddie and Damian Skinner
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
N/A
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:
17/03/2022
Nature of transaction: Distribution in specie
Name of any other party or parties to the transaction (if known):
Manu Caddie and Damian Skinne
r
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
No cash consideration as the
transactions are distributions in
specie. The value of the shares
being transferred is approximately
$2,449,003.11
Number of financial products to which the transaction related:
5,421,747
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
Yes
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Yes
Date of the prior written clearance (if any):
15/03/2022
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Rua
Nature of the affected relevant interest(s):
Manu is a director and 50%
shareholder of NZNL. NZNL is
distributing in specie 2,682,192
ordinary shares in Rua to Manu.
For that relevant interest-
Number held in class before acquisition or disposal:
194,106
Number held in class after acquisition or disposal:
2,876,298
Current registered holder(s):
NZNL
Registered holder(s) once transfers are registered:
Manu Caddie
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
N/A
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:
17/03/2022
Nature of transaction: Distribution in specie
Name of any other party or parties to the transaction (if known):NZNL
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
No cash consideration as the
transaction is a distribution in specie.
The value of the consideration is
approximately $1,211,546.12
Number of financial products to which the transaction relates:
2,682,192
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—

Whether relevant interests were acquired or disposed of during a closed period:
Yes
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Yes
Date of the prior written clearance (if any):
15/03/2022
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Ordinary shares in Rua
Nature of relevant interest:
Manu is a director and 50%
shareholder of NZNL. NZNL is a
limited partner of Hikurangi
Bioactives Limited Partnership
(HBLP) with a 40% economic
interest in HBLP
For that relevant interest,-
Number held in class:1,600,000
Current registered holder(s):HBLP
For a derivative relevant interest,-
Type of derivative:N/A
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative (if any):
N/A
The price's specified terms (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
N/A
For that derivative relevant interest,-
N/A
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
Signature of director or officer:
Date of signature:17-Mar-22
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:

---

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Rua Bioscience Limited (Rua)
Date this disclosure made:
17-Mar-22
Date of last disclosure:
8-Jun-21
Director or senior manager giving disclosure
Full name(s):
Manu Caddie
Name of listed issuer:
Rua Bioscience Limited
Name of related body corporate (if applicable):
Position held in listed issuer:
Kaihautu - Head of Innovation and
Regulation of Rua
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Rua
Nature of the affected relevant interest(s):
Manu is the holder of 2,876,298
(before the transaction) and 194,106
(after the transaction) ordinary
shares in Rua.
For that relevant interest-
Number held in class before acquisition or disposal:
2,876,298
Number held in class after acquisition or disposal:
194,106
Current registered holder(s):
Manu Caddie
Registered holder(s) once transfers are registered:
Enquire Limited
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
N/A
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:
17/03/2022
Nature of transaction: Off-market sale
Name of any other party or parties to the transaction (if known):Enquire Limited
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:NZ$1,211,546.12
Number of financial products to which the transaction relates:
2,682,192
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
Yes
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Yes
Date of the prior written clearance (if any):
15/03/2022
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Rua
Nature of the affected relevant interest(s):
Manu is a director and 50%
shareholder of Enquire Limited.
Enquire Limited is the holder of nil
(before the transaction) and
2,682,192 (after the transaction)
ordinary shares in Rua.
For that relevant interest-
Number held in class before acquisition or disposal:
0
Number held in class after acquisition or disposal:
2,682,192
Current registered holder(s):
Manu Caddie
Registered holder(s) once transfers are registered:
Enquire Limited
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
N/A
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:
17/03/2022
Nature of transaction: Off-market purchase
Name of any other party or parties to the transaction (if known):Enquire Limited
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:NZ$1,211,546.12
Number of financial products to which the transaction related:
2,682,192

If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
Yes
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Yes
Date of the prior written clearance (if any):
15/03/2022
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Ordinary shares in Rua
Nature of relevant interest:
Manu is a director and 50%
shareholder of New Zealand
Nutraceuticals Limited (NZNL).
NZNL is a limited partner of
Hikurangi Bioactives Limited
Partnership (HBLP) with a 40%
economic interest in HBLP
For that relevant interest,-
Number held in class:1,600,000
Current registered holder(s):HBLP
For a derivative relevant interest,-
Type of derivative:N/A
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative (if any):
N/A
The price's specified terms (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative relevant interest,-
N/A
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:17-Mar-22
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person: